Analyze Diet

Topic:Cushing's Syndrome

Cushing's Syndrome, also known as Pituitary Pars Intermedia Dysfunction (PPID), is a common endocrine disorder in horses characterized by an overproduction of certain hormones due to dysfunction of the pituitary gland. This condition primarily affects older horses and is associated with a variety of clinical signs including hirsutism, laminitis, and abnormal fat distribution. The underlying pathophysiology involves the degeneration of dopaminergic neurons, leading to excessive production of adrenocorticotropic hormone (ACTH). Diagnosis often involves measuring ACTH levels and performing dynamic endocrine tests. This page compiles peer-reviewed research studies and scholarly articles that explore the pathogenesis, diagnostic approaches, and management strategies for Cushing's Syndrome in equine populations.
Vascular Dysfunction in Horses with Endocrinopathic Laminitis.
PloS one    September 29, 2016   Volume 11, Issue 9 e0163815 doi: 10.1371/journal.pone.0163815
Morgan RA, Keen JA, Walker BR, Hadoke PW.Endocrinopathic laminitis (EL) is a vascular condition of the equine hoof resulting in severe lameness with both welfare and economic implications. EL occurs in association with equine metabolic syndrome and equine Cushing's disease. Vascular dysfunction, most commonly due to endothelial dysfunction, is associated with cardiovascular risk in people with metabolic syndrome and Cushing's syndrome. We tested the hypothesis that horses with EL have vascular, specifically endothelial, dysfunction. Healthy horses (n = 6) and horses with EL (n = 6) destined for euthanasia were recruited. We studied v...
Homeopathic prescribing for chronic conditions in equine veterinary practice in the UK.
The Veterinary record    February 23, 2010   Volume 166, Issue 8 234-238 doi: 10.1136/vr.b4764
Mathie RT, Baitson ES, Hansen L, Elliott MF, Hoare J.Twelve Faculty of Homeopathy veterinarians recorded data systematically at 777 consecutive homeopathic appointments for horses over a period of 12 months. A spreadsheet enabled the recording of information, which included the date of appointment; horse and owner identity (anonymised); sex of horse; main medical problem treated; whether the condition was chronic or acute; whether the appointment was new or a follow-up; owner-assessed clinical outcome on a seven-point scale, ranging from -3 to +3, compared with the first appointment; homeopathic medicine(s) prescribed; and whether any convention...
Cushing’s syndrome in a guinea pig.
The Veterinary record    June 26, 2007   Volume 160, Issue 25 878-880 doi: 10.1136/vr.160.25.878
Zeugswetter F, Fenske M, Hassan J, Künzel F.No abstract available
Effectiveness of acupuncture in veterinary medicine: systematic review.
Journal of veterinary internal medicine    June 1, 2006   Volume 20, Issue 3 480-488 doi: 10.1892/0891-6640(2006)20[480:eoaivm]2.0.co;2
Habacher G, Pittler MH, Ernst E.Acupuncture is a popular complementary treatment option in human medicine. Increasingly, owners also seek acupuncture for their animals. The aim of the systematic review reported here was to summarize and assess the clinical evidence for or against the effectiveness of acupuncture in veterinary medicine. Systematic searches were conducted on Medline, Embase, Amed, Cinahl, Japana Centra Revuo Medicina and Chikusan Bunken Kensaku. Hand-searches included conference proceedings, bibliographies, and contact with experts and veterinary acupuncture associations. There were no restrictions regarding t...
Cushing’s syndromes, insulin resistance and endocrinopathic laminitis.
Equine veterinary journal    May 19, 2004   Volume 36, Issue 3 194-198 doi: 10.2746/0425164044877279
Johnson PJ, Messer NT, Ganjam VK.No abstract available
Efficacy of trilostane for the treatment of equine Cushing’s syndrome.
Equine veterinary journal    July 26, 2003   Volume 35, Issue 4 414-418 doi: 10.2746/042516403776014271
McGowan CM, Neiger R.Trilostane, a competitive 3-beta hydroxysteroid dehydrogenase inhibitor, has been used successfully to control clinical signs and cortisol excess in canine pituitary dependent hyperadrenocorticism. Objective: Trilostane was evaluated for its efficacy in resolving clinical and clinicopathological abnormalities of equine Cushing's syndrome (ECS) and to assess its safety. Methods: Twenty horses (mean age 21 years) diagnosed with ECS were followed for 1 or 2 years. Affected horses received 0.4-1 mg/kg (mean 0.5 mg/kg) trilostane once daily. Results: Clinical signs assessed over 1 or 2 years, showe...
Cushing’s disease: a new approach to therapy in equine and canine patients.
The British homoeopathic journal    February 24, 2001   Volume 90, Issue 1 33-36 doi: 10.1054/homp.1999.0450
Elliott M.Forty-one cases of Cushing's Disease affecting both equine and canine patients were treated with an identical mixture of two homeopathically prepared remedies (ACTH 30c and Quercus robur 30c), and the clinical improvements seen in the cases assessed. Homeopathy has been described as a medicine that can only be prescribed on the basis of individual symptoms shown, fitting the remedy to the patient, not the disease. The aim of this study was to define whether a standardised approach, using homeopathically prepared remedies, was a valid system of therapy for this disease, and if so, whether resul...
Problems in the diagnosis of pituitary adenoma (Cushing’s syndrome) in horses.
New Zealand veterinary journal    April 1, 1995   Volume 43, Issue 2 79-82 doi: 10.1080/00480169.1995.35854
Thompson JC, Ellison R, Gillett R, Badcoe L.Thyrotropin releasing hormone (TRH) stimulation tests were carried out on a number of horses, including one clinically affected horse whose age and clinical signs suggested that a pituitary adenoma was most unlikely. The results of these tests indicated that, according to criteria published overseas, the majority of these horses had pituitary adenomas. The fact that clinically normal or affected horses may have marked increases in cortisol concentrations indicates that the TRH stimulation test is not suitable for the diagnosis of pituitary adenoma. Other tests, including alterations in glucose...
Animal models of Cushing’s disease.
Trends in endocrinology and metabolism: TEM    January 1, 1994   Volume 5, Issue 1 21-28 doi: 10.1016/1043-2760(94)90117-1
Kemppainen RJ, E Peterson M.Cushing's disease, defined as hyperadrenocorticism resulting from excessive secretion of pituitary ACTH, occurs spontaneously and quite commonly in dogs and horses. In dogs, as in humans, the disease is usually associated with a small tumor of the pituitary pars distalis. However, the disease may arise occasionally (dogs) or exclusively (horses) from tumors or hyperplasia of the pituitary pars intermedia. In dogs, pars intermedia tumors may arise from one of two proopiomelanocortin-containing cell types that are present in normal tissue.
Proopiolipomelanocortin peptides in normal pituitary, pituitary tumor, and plasma of normal and Cushing’s horses.
Endocrinology    March 1, 1982   Volume 110, Issue 3 941-954 doi: 10.1210/endo-110-3-941
Wilson MG, Nicholson WE, Holscher MA, Sherrell BJ, Mount CD, Orth DN.Using RIAs for six regions within proopiolipomelanocortin (proOLMC), gel filtration, and electrophoresis, we studied pituitary peptides in a normal horse and one with Cushing's disease caused by a pars intermedia adenoma. Almost all immunoreactive (IR) ACTH (78%) was 4,500 mol wt (4.5K) ACTH in normal pars distalis, but it was almost 100% corticotropin-like intermediate lobe peptide (CLIP) in normal pars intermedia. alpha MSH and beta MSH were found mainly in pars intermedia: equal concentrations of the beta MSH precursors, beta-lipotropin (beta LPH) and gamma LPH, were found in pars distalis....
A case of pituitary adrenocorticotropin-dependent Cushing’s syndrome in the horse.
Endocrinology    March 1, 1979   Volume 104, Issue 3 576-582 doi: 10.1210/endo-104-3-576
Moore JN, Steiss J, Nicholson WE, Orth DN.In the horse, a syndrome of hirsutism, hyperglycemia, glucosuria, polydipsia, polyuria, polyphagia, and progressive debilitation has been recognized. Most often the syndrome has been associated with adenomas of the pars intermedia of the pituitary and bilateral adrenal hyperplasia or nodular hyperplasia involving primarily the zona fasciculata. Previously, the syndrome has been ascribed to compression of the hypothalamus by an expanding but functionally inactive pituitary neoplasm. In the present case, with RIA determination of plasma ACTH concentrations, the syndrome was ascribed to pituitary...